production of large, immune-compatible tissue therapeutics that precisely mimic human physiology. By combining a variety of biomaterials and cell types, seamless integration and functionality is achieved. Cellbricks aims to eliminate the need for autologous tissue transfers and the long wait for donor organs, ultimately enabling patients to live longer, healthier lives.